Investment
Features
FeesSafety
Academy
More
Pluang+

The Doctors Company acquires ProAssurance for $1.3B, creating a $12B medical malpractice insurer.

Company Fundamentals
26 Jun 2026
PRNewsWire
View Source
Bullish
pluang ai news

The Doctors Company, the largest physician-owned medical malpractice insurer in the U.S., has completed its acquisition of ProAssurance Corporation for approximately $1.3 billion in cash. This merger creates a combined company with $12 billion in assets, protecting over 200,000 healthcare professionals and organizations nationwide. ProAssurance will operate as a wholly owned subsidiary while the new company reviews its optimal operating structure. This acquisition strengthens their position as a leading insurer in medical liability and specialty lines, aiming to provide enhanced service and stability in the healthcare insurance market.

More News

Nvidia's strong earnings outlook fuels analyst optimism and potential stock valuation upside.

Nvidia's strong earnings outlook fuels analyst optimism and potential stock valuation upside.

Nvidia, a leading semiconductor and AI company, is expected to report strong Q2 fiscal 2027 earnings on August 26, with analysts anticipating revenue around $91.9 billion and adjusted earnings of $2.08 per share. RBC Capital maintains an "Outperform"...

Analyst Insights
Bullish
1 hour ago
Deere & Company beats Q3 earnings and revenue estimates, driven by strong construction equipment sales.

Deere & Company beats Q3 earnings and revenue estimates, driven by strong construction equipment sales.

Deere & Company reported third-quarter earnings per share of $5.10, surpassing analyst expectations of $4.71, and revenue of $12.61 billion, exceeding estimates of $10.81 billion. The growth was mainly driven by strong performance in the construction...

Company Fundamentals
Bullish
1 hour ago
AbbVie price target raised to $303 as institutional investors boost holdings, signaling strong confidence.

AbbVie price target raised to $303 as institutional investors boost holdings, signaling strong confidence.

Piper Sandler raised AbbVie's price target to $303, indicating a potential 13.92% upside from its current price of $265.97. This reflects positive expectations for the biopharmaceutical company's future performance. Institutional investors like J. M....

Analyst Insights
Bullish
1 hour ago
BTIG raises Glaukos price target to $202 on strong sales growth and raised 2026 revenue guidance.

BTIG raises Glaukos price target to $202 on strong sales growth and raised 2026 revenue guidance.

BTIG reaffirmed its 'Buy' rating for Glaukos and increased the price target to $202, citing strong sales growth. U.S. glaucoma sales rose 64% to $118.5 million, driven by the iDose TR product, while Corneal Health revenues grew 48% to $30.4 million, ...

Analyst Insights
Bullish
1 hour ago
Nearly 30% of Berkshire Hathaway's $356B portfolio is in two AI stocks, highlighting AI's growing investment appeal.

Nearly 30% of Berkshire Hathaway's $356B portfolio is in two AI stocks, highlighting AI's growing investment appeal.

Berkshire Hathaway has allocated 29.7% of its $356 billion investment portfolio to just two artificial intelligence stocks. This significant concentration underscores the growing confidence and interest in AI technologies as key drivers of future gro...

Market News
Bearish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App